Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

Location: Office-based/hybrid with 3 days onsite in El Segundo, Thousand Oaks, or Foster City, California, United States

Salary: $226,185–$292,710 base compensation for Bay Area locations; $205,615–$266,090 for other US locations. The role may also include a discretionary annual bonus, stock-based long-term incentives, paid time off, and benefits.

Company

hirify.global is a biopharmaceutical company developing cancer immunotherapies, including CAR T-cell and T-cell receptor engineered cell therapies.

What you will do

• Lead global value and access strategies for autoimmune cell-therapy programs from early development through launch and lifecycle management.
• Integrate payer, HTA, and health-system perspectives into development, evidence generation, pricing, reimbursement, and commercialization strategies.
• Partner with regional and country access teams to develop global-to-local reimbursement strategies across major markets, including the US, EU5, Canada, Australia, and Japan.
• Guide target product profiles, clinical development plans, endpoint selection, comparator strategy, study design, and payer-focused evidence generation.
• Lead early payer engagement and HTA scientific advice strategies across multiple autoimmune indications.
• Collaborate with Clinical Development, HEOR/RWE, Medical Affairs, Commercial, Regulatory Affairs, Pricing, and regional Access teams to shape value propositions and launch readiness.

Requirements

• 8+ years of experience with a PhD or PharmD; 10+ years with an MS/MA, MBA, PharmD, PhD, or equivalent advanced degree; or 12+ years with a BS/BA.
• 3+ years of direct experience supporting autoimmune disease programs, including development-stage assets, clinical strategy, market access, medical affairs, or commercial strategy.
• Experience in pharmaceutical or biotechnology market access, pricing, reimbursement, HEOR, commercial strategy, or related functions.
• Experience incorporating payer, HTA, and health-system requirements into clinical development and evidence-generation strategies.
• Strong understanding of global payer, pricing, reimbursement, and HTA landscapes, including US formulary and utilization-management dynamics.
• Strong strategic, analytical, communication, problem-solving, and cross-functional leadership skills in a matrix environment.

Nice to have

• Experience with advanced therapies, including cell therapy or gene therapy.
• Deep understanding of autoimmune treatment paradigms, competitive dynamics, and unmet patient needs.
• Experience with value frameworks, economic models, burden-of-illness studies, indirect treatment comparisons, and payer-focused evidence packages.
• Experience supporting global launch planning, launch readiness, and lifecycle management.

Culture & Benefits

• Inclusive leadership focused on diversity, belonging, talent development, and empowered teams.
• Medical, dental, vision, and life insurance plans for eligible employees.
• Paid time off and potential eligibility for annual bonuses and stock-based long-term incentives.
• Fast-paced environment focused on innovation and the development of transformative cancer and autoimmune cell therapies.